Issued Patents All Time
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12358929 | NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger, Yuelian Xu | 2025-07-15 |
| 12161624 | Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B | David R. Anderson, Robert A. Volkmann | 2024-12-10 |
| 12162890 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger | 2024-12-10 |
| 12145909 | N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B | David R. Anderson, Robert A. Volkmann | 2024-11-19 |
| 11807650 | NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger, Yuelian Xu | 2023-11-07 |
| 11648253 | Thienopyrimidinone NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger | 2023-05-16 |
| 11541057 | Thienopyrimidinone NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger | 2023-01-03 |
| 11274107 | NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger, Yuelian Xu | 2022-03-15 |
| 11236104 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger | 2022-02-01 |
| 11116749 | Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B | David R. Anderson, Robert A. Volkmann | 2021-09-14 |
| 10973825 | Thienopyrimidinone NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger | 2021-04-13 |
| 10781174 | N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B | David R. Anderson, Robert A. Volkmann | 2020-09-22 |
| 10626122 | Heteroaromatic NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger | 2020-04-21 |
| 10500205 | Thienopyrimidinone NMDA receptor modulators and uses thereof | David R. Anderson, Robert A. Volkmann, Christopher Fanger | 2019-12-10 |
| 10239835 | N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of NR2B | David R. Anderson, Robert A. Volkmann | 2019-03-26 |
| 10052306 | Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B | David R. Anderson, Robert A. Volkmann | 2018-08-21 |
| 9540324 | Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B | David R. Anderson, Robert A. Volkmann | 2017-01-10 |
| 7078529 | Imidazole derivatives | Mark Sanner, Chris Helal, Christoper B. Cooper, Patricia Seymour, Michael Ahlijanian +2 more | 2006-07-18 |
| 7019016 | NMDA NR2B antagonists for treatment | Bertrand L. Chenard, Mario Saltarelli | 2006-03-28 |
| 6958351 | NMDA NR2B antagonists for treatment | Bertrand L. Chenard, Mario Saltarelli | 2005-10-25 |
| 6821985 | Pharmaceutical combinations for the treatment of stroke and traumatic brain injury | Bertrand L. Chenard, Mario Saltarelli | 2004-11-23 |
| 6756385 | Imidazole derivatives | Mark Sanner, Chris Helal, Christoper B. Cooper, Michael Ahlijanian, Annabella Villalobos +2 more | 2004-06-29 |
| 6667317 | Pharmaceutical combinations for the treatment of stroke and traumatic brain injury | Bertrand L. Chenard, Mario Saltarelli | 2003-12-23 |
| 6258827 | Combinations for the treatment of parkinsonism containing selective NMDA antagonists | Bertrand L. Chenard | 2001-07-10 |
| 6136812 | Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy | Bertrand L. Chenard, Willard M. Welch, Jr. | 2000-10-24 |